Zum Inhalt springen
- {{#headlines}}
- {{title}} {{/headlines}}
Profil
| Derzeitige Stellung | Professor W-3 und Äquivalente |
|---|---|
| Fachgebiet | Molekulare Biologie und Physiologie von Nerven- und Gliazellen,Zellbiologie,Allgemeine Genetik und funktionelle Genomforschung |
| Keywords | human genetics of disease susceptibility, TRP ion channels, neuroprotection - neuronal chloride, molecular neurobiology of neurodegeneration, molecular neurobiology of pain and itch |
| Auszeichnungen | 2020: Yale University, Innovation-to-Impact Entrepreneurship Program Fellow 2019: Blaustein Pain Lecture, Johns Hopkins University School of Medicine 2019: Duke University, Distinguished Nominee Leonard Tow Award for Humanism in Medicine 2018: Duke University, Distinguished Nominee Leonard Tow Award for Humanism in Medicine 2017: Duke University Chancellor's Discovery Program 2013: Scholar-Innovator (inaugural class), Harrington Discovery Institute, Cleveland OH 2011: Ruth K Broad Duke Neuroscience Faculty Scholar, Ruth K Broad Foundation, Durham NC 2004: Klingenstein Fellowship in Neuroscience, Ebert Clinical Scholar, Klingenstein Fund, New York NY 2002: K08 Clinical Scientist Development Award (NIH-NIMH) 2001: Group Leader, "Projekt Talent" of BMBF - German Federal Ministry of Education and Research 1998: Henry L. Moses Award of Yeshiva University, 1st Prize Basic Sciences 1994: Feodor Lynen Fellow AvH 1985: Scholar, German Academic Scholarship Foundation, Bonn, Germany |
Aktuelle Kontaktadresse
| Land | USA |
|---|---|
| Ort | Tarrytown |
| Universität/Institution | Regeneron Pharmaceuticals Inc. |
| Website | https://www.linkedin.com/in/wolfgang-liedtke-91768720b/ |
Gastgeber*innen während der Förderung
| Prof. Dr. Patric Kevin Stanton | Albert Einstein College of Medicine, Yeshiva University, New York |
|---|---|
| Prof. Dr. Cedric S. Raine | Albert Einstein College of Medicine, Yeshiva University, New York |
| Beginn der ersten Förderung | 01.05.1994 |
Programm(e)
| 1993 | Feodor Lynen-Forschungsstipendien-Programm |
|---|
Publikationen (Auswahl)
| 2003 | Wolfgang Liedtke and Jeffrey M. Friedman: Abnormal osmotic regulation in trpv4-/- mice. In: PNAS, 2003, 13698-13703 |
|---|---|
| 2003 | Wolfgang Liedtke, David M. Tobin, Cornelia I. Bargmann, and Jeffrey M. Friedmann: Mammalian TRPV4 (VR-OAC) directs behavioral responses to osmotic and mechanical stimuli in Caenorhabditis elegans. In: PNAS, 2003, 14531-14536 |
| 2002 | Wolfgang Liedtke, Elizabeth E. Leman, Robert E.W. Fyffe, Cedric S. Raine, Ulrich K. Schubart: Stathmin-deficient mice develop an age-dependent axonopathy of the central and peripheral nervous system.. In: American Journal of Pathology, 2002, 469-480 |
| 2000 | Wolfgang Liedtke, Yong Choe, Marc A. Marti-Renom, Andrea M. Bell, Charlotte S. Denis, Andrej Sali, Albert James Hudspeth, Jeffrey M. Friedman, Stefan Heller: Vanilloid Receptor Related Osmotically Activated Channel (VR-OAC), a candidate vertebrate osmoreceptor. In: Cell, 2000, 525-535 |
| 1998 | Wolfgang Liedtke, Barbara Cannella, Richard J. Mazzaccaro, John M. Clements, Karen M. Miller, Kai W. Wucherpfennig, Andrew J.H. Gearing, Cedric S. Raine.: Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors. In: Annals of Neurology, 1998, 35-46 |
| 1998 | Wolfgang Liedtke, Winfried Edelmann, F.C. Chiu, Raju Kucherlapati, Cedric S. Raine. Experimental autoimmune encephalomyelitis in mice lacking glial fibrillary acidic protein is characterized by a more severe clinical course and an infiltrative central nervous system lesion. In: American Journal of Pathology, 1998, 251-259 |
| 1996 | Wolfgang Liedtke, Gery Meyer, Pedro M. Faustmann, Hermut Warnatz, Cedric S. Raine. Clonal expansion and decreased occurrence of peripheral blood gamma-delta T cells of the Vdelta2-Jdelta3 lineage in multiple sclerosis patients. In: International Immunology, 1996, 1031-1041 |
| 1996 | Wolfgang Liedtke, Winfried Edelmann, Phylis L. Bierri, F.C. Chiu, Nick Cowan, Raju Kucherlapati, Cedric S. Raine. GFAP is necessary for the integrity of CNS white matter architecture and the long-term maintenance of myelination. In: Neuron, 1996, 607-615 |
| 1996 | Wolfgang Liedtke, Volker Limmroth: Validity of brain magnetic resonance imaging as the primary outcome criterion in multiple sclerosis phase II clinical trials. In: Annals of Neurology, 1996, 276 |